Skip to main content
. 2015 Oct 15;8(10):18954–18962.

Table 2.

Short-term efficacies of monotherapy and combination therapies [% (case)]

Group CR PR SD PD RR
Combination therapy 12.5% (4) 68.8% (22) 21.9% (7) 3.13% (1) 81.3% (26)
Monotherapy 3.13% (1) 43.8% (14) 25% (8) 18.8% (6) 46.9% (15)

Abbreviations: CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; RR, response rate.